(66 intermediate revisions by the same user not shown)
Line 1:
Line 1:
== Omar F. Khan ==
== Omar F. Khan ==
[[Image:OF_Khan.jpg|thumb|left|Omar F. Khan]]
[[Image:KI.jpg|thumb|left|Omar F. Khan]]
Hi, my name is Omar F. Khan, and I'm currently at University of Toronto. I learned about [[OpenWetWare]] from Professor Axel Guenther, and I've joined because Fabrication of microfluidic devices. You can [[Special:Emailuser/Omar F. Khan|email me through OpenWetWare]]. I am a serving member of the [http://openwetware.org/wiki/TorontoMicrofluidicsFoundry Toronto Microfluidic Foundry's] Process Technology Committee.
Hi, my name is [http://scholar.google.com/citations?user=XlkJ88EAAAAJ Omar F. Khan], and I'm currently at the [http://web.mit.edu/ Massachusetts Institute of Technology]. I work in the labs of Professors [http://web.mit.edu/langerlab/ Robert Langer] and [http://hst.mit.edu/users/dgandermitedu Daniel G. Anderson] within the [http://ki.mit.edu David H. Koch Institute for Integrative Cancer Research]. I did my PhD in Chemical Engineering at the [http://www.utoronto.ca University of Toronto] under the supervision of [http://seftonlab.utoronto.ca/aboutsefton.html Professor Michael V. Sefton].
== Education ==
I work towards the treatment of damaged tissues and organs by combining nanotechnology and tissue engineering. I also make universal vaccine platforms using my nanotechnology. Recently, my work was featured in the [http://ki-galleries.mit.edu/2014/khan Koch Institute Public Galleries] at MIT. To see a brief video of me describing some of my nanotechnology work, click [https://youtu.be/06mjfaP4jHY here].
Ph.D., Chemical Engineering and Applied Chemistry/Institute of Biomaterials and Biomedical Engineering, University of Toronto (current)
== Work ==
Postdoctoral Associate, Langer and Anderson Labs, Massachusetts Institute of Technology
M.A.Sc., Chemical Engineering and Applied Chemistry/Institute of Biomaterials and Biomedical Engineering, University of Toronto, 2006
Please visit my main [http://web.mit.edu/ofk/www/ website] for more information: [http://web.mit.edu/ofk/www/ http://web.mit.edu/ofk/www/]
B.A.Sc.(Honors), Chemical Engineering, University of Toronto, 2004
== Publications and Communications ==
Khan, O.F. and Sefton, M.V. Perfusion and Characterization of an Endothelial Cell-Seeded Modular Tissue Engineered Construct Formed in a Microfluidic Remodeling Chamber. Biomaterials (2010), doi:10.1016/j.biomaterials.2010.07.041
Khan, O.F., Jean-Francois, J. and Sefton, M.V. MMP levels in the response to degradable implants in the presence of a hydroxamate-based matrix metalloproteinase sequestering biomaterial in vivo. Journal of Biomedical Materials Research, Part A, 2010 Jun 15;93(4):1368-79.
Sosnik A., Khan O.F., Butler M, Sefton M.V.: Poloxamine hydrogels: From non-cell adhesive substrates to matrices with improved cytocompatibility for Tissue Engineering applications. In Barbucci, R. (Ed.), Hydrogels: Biological Properties and Applications. Springer; 2009.
Chamberlain, M.D., Butler, M.J., Ciucurel, E.C., Fitzpatrick, L.E., Khan, O.F., Leung, B.M., Lo, C., Patel, R., Velchinskaya, A., Voice, D.N. and Sefton, M.V. Fabrication of micro-tissues using modules of collagen gel containing cells. Journal of Visualized Experiments (In Press)
Khan, O.F., Chamberlain, M.D. and Sefton, M.V. “Modular Tissue Containing Endothelial Cells and Mesenchymal Stem Cells formed in a Microfluidic Perfusion Chamber.” Tissue Engineering and Regenerative Medicine International Society (TERMIS)-EU Chapter Meeting, Galway, Ireland, June 13-17, 2010. Oral Presentation
Khan, O.F., Leung, B.M. and Sefton, M.V. “Modular Cardiac Tissue Containing Endothelial and Cardiomyocyte Cells formed in a Microfluidic Perfusion Chamber,” Ontario-on-a-Chip, Toronto, ON., Canada, May 20-21, 2010. Oral Presentation
Khan, O.F. and Sefton, M.V. “Collagen/Poloxamine Microfluidic Flow Circuits to Characterize Surface-Attached Endothelial Cells Under Flow.” 8th World Biomaterials Congress, Amsterdam, The Netherlands, May 28-June 1, 2008. Oral Presentation
Khan, O.F. and Sefton, M.V. “In Vivo Use of a Matrix Metalloproteinase-Sequestering Biomaterial to Alter the Inflammatory Response,” Regenerate World Congress on Tissue Engineering and Regenerative Medicine, Pittsburgh, Pennsylvania, USA, April 23-27, 2006. Poster Presentation
Khan, O.F. and Sefton, M.V. “In Vivo Alteration of the Foreign Body Response Using a Matrix Metalloproteinase-Sequestering Biomaterial,” Challenges in Regenerative Medicine (ChaRM), Toronto, Ontario, Canada, October 20-21, 2005. Poster Presentation
== Lab Info ==
Professor Michael V. Sefton, supervisor
Centre for Cellular and Biomolecular Research,
160 College Street, Room 440
Toronto, Ontario
Canada M5S3E1
[http://www.ibbme.utoronto.ca/faculty/core/sefton.htm Research Highlights]
== Basic Wiki Instructions ==
Editing pages:Here's an extensive list of [http://en.wikipedia.org/wiki/Wikipedia:Tutorial_%28Formatting%29 formating examples]. Or look at this OpenWetWare [[OpenWetWare:Welcome|introductory tutorial]].
For examples, check out [[User:Julius_B._Lucks]], [[User:Jason_R._Kelly]] and [[User:Reshma_P._Shetty]].
I work towards the treatment of damaged tissues and organs by combining nanotechnology and tissue engineering. I also make universal vaccine platforms using my nanotechnology. Recently, my work was featured in the Koch Institute Public Galleries at MIT. To see a brief video of me describing some of my nanotechnology work, click here.
Work
Postdoctoral Associate, Langer and Anderson Labs, Massachusetts Institute of Technology
